Lemaitre Vascular Stock News

BURLINGTON, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 21st Annual Needham Virtual

BURLINGTON, Mass., March 01, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four upcoming investor conferences in March.

BURLINGTON, Mass., March 01, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four upcoming investor conferences in March.

LeMaitre Vascular (NASDAQ:LMAT) declares $0.125/share quarterly dividend, 13.6% increase from prior dividend of $0.110.Forward yield 1.09%Payable March 24; for shareholders of record March…

LeMaitre Vascular press release (LMAT): Q4 GAAP EPS of $0.28 misses by $0.03.Revenue of $39.5M (+5.3% Y/Y) misses by $0.2M.Q1 2022 Guidance: Sales of $37.7M - $39.7M (consensus…

LeMaitre Vascular press release (LMAT): Q4 GAAP EPS of $0.28 misses by $0.03.Revenue of $39.5M (+5.3% Y/Y) misses by $0.2M.Q1 2022 Guidance: Sales of $37.7M - $39.7M (consensus…

LeMaitre Vascular's (LMAT) CEO George LeMaitre on Q4 2021 Results - Earnings Call Transcript

LeMaitre (LMAT) delivered earnings and revenue surprises of -9.68% and 0.66%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

LeMaitre Vascular (NASDAQ:LMAT) is scheduled to announce Q4 earnings results on Thursday, Feb. 24, after market close.The consensus EPS estimate is $0.31

New York, USA, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Peripheral Vascular Devices Market is Estimated to Surpass USD 13 Billion by 2026 As per DelveInsight analysis, the demand for Peripheral Vascular Devices is increasing due to the rapid rise in cardiovascular and peripheral vascular diseases prevalence, as well as the approval of new and improved products by market players along with the rising frequency of lifestyle disorders such as diabetes and hypertension. DelveInsight''s Peripheral Vascular Devices Market Insights report provides the current and forecast Peripheral Vascular Devices market, upcoming device innovation, individual market shares, challenges, drivers, barriers, and market trends and key Peripheral Vascular Device companies in the market. Key Takeaways from the Peripheral Vascular Devices Market report According to DelveInsight analysis, North America is expected to dominate the Peripheral Vascular Devices market during the forecast period. Key Peripheral Vascular Device companies working in the global market are Medtronic, Boston Scientific Corporation, B.

BURLINGTON, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2021 financial results on Thursday, February 24, 2022, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.

BURLINGTON, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the BTIG MedTech, Digital Health

AHCO vs. LMAT: Which Stock Is the Better Value Option?

BURLINGTON, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 24th Annual Needham Virtual

Tygh Capital Management Inc. cut its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 36.2% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 125,251 shares of the medical instruments suppliers stock after selling 71,094 shares during the period. Tygh Capital Management Inc.s holdings in LeMaitre Vascular were worth $6,650,000 as of its most []